GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS

본 발명은 유전적으로 변형된 인간 탯줄 혈관주위 세포를 투여함으로써, 대상 (예를 들어, 포유동물, 예를 들어 인간)에서 생물학적 또는 화학적 물질에 의해 유발된 질병 또는 질환을 예방 또는 치료하는 방법을 제공한다. The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by ad...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DAVIES JOHN EDWARD, ENNIS JANE ELIZABETH, TURNER JEFFREY DONALD
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	본 발명은 유전적으로 변형된 인간 탯줄 혈관주위 세포를 투여함으로써, 대상 (예를 들어, 포유동물, 예를 들어 인간)에서 생물학적 또는 화학적 물질에 의해 유발된 질병 또는 질환을 예방 또는 치료하는 방법을 제공한다. The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.